Published in Eur J Gastroenterol Hepatol on March 01, 2006
Timing of surgery in Crohn's disease: a key issue in the management. World J Gastroenterol (2008) 0.98
Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. Am J Gastroenterol (2010) 0.92
Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease. World J Gastroenterol (2011) 0.83
Optimising the Inflammatory Bowel Disease Unit to Improve Quality of Care: Expert Recommendations. J Crohns Colitis (2015) 0.78
Quality of health care in the United States: implications for pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2009) 0.77
Web-based interventions for ulcerative colitis and Crohn's disease: systematic review and future directions. Clin Exp Gastroenterol (2015) 0.77
Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations: A Cohort Study. Inflamm Bowel Dis (2016) 0.75
What Do Participants of the Crohn's and Colitis UK (CCUK) Annual York Walk Think of Their Inflammatory Bowel Disease Care? A Short Report on a Survey. Gastroenterol Nurs (2016) 0.75
Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol (2011) 5.66
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol (2010) 2.52
Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis (2005) 2.47
Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr (2012) 1.51
Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol (2005) 1.43
Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease. Inflamm Bowel Dis (2011) 1.36
The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology (2006) 1.24
Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol (2004) 1.22
Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies. Gastroenterology (2007) 1.19
Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis (2008) 1.18
The role of psychological stress in inflammatory bowel disease. Neuroimmunomodulation (2007) 1.16
Formation of platelet-leukocyte aggregates in inflammatory bowel disease. Inflamm Bowel Dis (2004) 1.12
New treatments for inflammatory bowel disease. World J Gastroenterol (1998) 1.09
Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflamm Bowel Dis (2002) 1.08
Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom. Am J Gastroenterol (2004) 1.05
Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.05
Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World J Gastroenterol (2008) 0.99
Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential. J Immunol (2011) 0.96
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all. Clin Gastroenterol Hepatol (2010) 0.95
Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption. Eur J Gastroenterol Hepatol (2010) 0.94
The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol (2008) 0.92
Optimization of conventional therapy in patients with IBD. Nat Rev Gastroenterol Hepatol (2011) 0.92
Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol. J Crohns Colitis (2012) 0.92
"Diversion" colitis caused by Clostridium difficile infection: report of a case. Dis Colon Rectum (2006) 0.88
Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practice. Eur J Gastroenterol Hepatol (2011) 0.87
Hair loss in patients with inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.87
Drug interactions in inflammatory bowel disease. Am J Gastroenterol (2007) 0.86
Platelet-leucocyte aggregates form in the mesenteric vasculature in patients with ulcerative colitis. Eur J Gastroenterol Hepatol (2008) 0.85
Does psychological counseling alter the natural history of inflammatory bowel disease? Inflamm Bowel Dis (2010) 0.85
Management of stress in inflammatory bowel disease: a therapeutic option? Expert Rev Gastroenterol Hepatol (2009) 0.84
Anti-infliximab antibodies in inflammatory bowel disease: prevalence, infusion reactions, immunosuppression and response, a meta-analysis. Eur J Gastroenterol Hepatol (2012) 0.83
Alopecia areata: a possible extraintestinal manifestation of Crohn's disease. J Crohns Colitis (2013) 0.82
Semiquantitative assessment of breath hydrogen testing. J Gastroenterol Hepatol (2013) 0.82
Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohn's Disease. Inflamm Bowel Dis (2015) 0.81
Oral iron therapy in inflammatory bowel disease: usage, tolerance, and efficacy. Inflamm Bowel Dis (2003) 0.81
Hidradenitis suppurativa: MRI features in anogenital disease. Dis Colon Rectum (2014) 0.79
Bile acid malabsorption in patients with graft-versus-host disease of the gastrointestinal tract. Br J Haematol (2012) 0.77
Toxicity and response to thiopurines in patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol (2015) 0.76
Optimizing conventional therapies for inflammatory bowel disease. Curr Gastroenterol Rep (2009) 0.76
New flow cytometric technique for the evaluation of circulating endothelial progenitor cell levels in various disease groups. J Immunol Methods (2006) 0.76
Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group. Gastroenterol Hepatol (N Y) (2008) 0.75
Leukocytapheresis in ulcerative colitis. Am J Gastroenterol (2006) 0.75
Biologics for inflammatory bowel diseases in the Asia-Pacific: can we afford to use them, can we afford not to? J Gastroenterol Hepatol (2009) 0.75
Acute mesenteric infarction: an important cause of abdominal pain in ulcerative colitis. Eur J Gastroenterol Hepatol (2005) 0.75
Diverticular disease of the colon. Lancet (2004) 0.75
Infliximab: getting the most for your money. J Gastroenterol Hepatol (2007) 0.75
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel. Inflamm Bowel Dis (2016) 0.75
Tobacco dependence and awareness of health risks of smoking in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol (2011) 0.75
Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standing Crohn's Disease. Inflamm Bowel Dis (2017) 0.75
The challenges of control groups, placebos and blinding in clinical trials of dietary interventions. Proc Nutr Soc (2017) 0.75
Inpatient diarrhoea and Clostridium difficile infection. Clin Med (2012) 0.75
Distinct management issues with Crohn's disease of the small intestine. Curr Opin Gastroenterol (2015) 0.75